Lilly faces lawsuit over alleged excessive retirement-plan fees
Eli Lilly and Co. is one of hundreds of U.S. companies being sued in the recent trend in litigation: excessive fees on 401(k) retirement plans.
Eli Lilly and Co.
Articles
Lilly whistleblower sues drugmaker, alleging retaliation
A top human resources officer at Eli Lilly and Co.’s factory in New Jersey claims the drugmaker fired her in retaliation for investigating employee complaints about drug manufacturing problems and for refusing to drop the matter.
Drug pricing enforcement action against Lilly blocked by federal court
The federal government’s assertion that Eli Lilly and Co. violated a program to offer low-income Medicaid and Medicare patients discounted drugs was tossed by the U.S. District Court for the Southern District of Indiana in a 65-page opinion, which also hinted that Congress needs to address the problems with the 340B Drug Pricing Program.
Lawsuit accuses Lilly of favoring millennials over older job applicants
Eli Lilly and Co. refuses to interview and hire older workers, systematically favoring recent college graduates and other younger applicants, a new lawsuit alleges.
IndyBar WLD Member of the Month: Sonia Chen Arnold, Eli Lilly
Lucy Dollens, IndyBar Women and the Law Division Executive Committee member, recently sat down with Sonia Chen Arnold, Senior Director, Assistant General Counsel- Consumer/Customer Operations at Eli Lilly and Company.
Former Eli Lilly lobbyist drops sex discrimination lawsuit
A former Washington, D.C., lobbyist for Eli Lilly and Co. has dropped her complaint against the Indianapolis-based drugmaker, in which she had claimed a top executive made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.
Indianapolis-area employers reluctant to require employee vaccinations
Around central Indiana, employers are offering plenty of incentives to encourage their workers to get vaccinations as part of an effort to keep their office towers, stores, warehouses and factory floors safe for co-workers and visitors. But few, if any, are requiring workers to get vaccinated.
Indiana panel drops contentious requirement from voting bill
A legislative committee has overhauled a contentious proposal to require Indiana voters to submit identification numbers with mail-in ballot applications.
Proposed Indiana voting law change faces Eli Lilly criticism
One of Indiana’s most prominent corporations is criticizing an Indiana proposal that opponents maintain will make mail-in voting more difficult by requiring voters to submit identification numbers with their ballot applications.
Lilly exec created hostile work environment for women, former lobbyist claims in suit
A former Washington, D.C., lobbyist for Eli Lilly and Co. claims a top executive at the company made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.
US allows emergency use of Lilly COVID-19 antibody drug
The Food and Drug Administration on Monday cleared emergency use of an experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.
Indiana could get first vaccine supply by mid-November, state officials say
No vaccine for COVID-19 has yet been approved by federal regulators, but Indiana health officials said Wednesday they expect to get an initial shipment of the first available vaccine by mid-November, and perhaps a second vaccine by December.
Lilly antibody drug fails in COVID-19 study for hospitalized patients
U.S. government officials are putting an early end to a study testing an Eli Lilly and Co. antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them. The Indianapolis-based drugmaker, however, is continuing to back the treatment.
Lilly seeks emergency use of its antibody drug for COVID-19
Indianapolis-based Eli Lilly and Company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.
Virtual CLE today focuses on patents, politics of COVID-19
The Indiana University Maurer School of Law, Eli Lilly & Co. and Roche are partnering for a virtual discussion today, “Pharmaceutical Innovations: Patents and the Politics of COVID-19.”
Lilly pledges $25M, 25,000 volunteer hours against injustice
Eli Lilly and Co. and the Lilly Foundation announced a pledge of $25 million and 25,000 employee volunteer service hours over five years Saturday to ease the burden of racial injustice and its effects on local and national communities of color.
17 new Indiana coronavirus cases reported, bringing total to 56
Seventeen new coronavirus cases have been confirmed around Indiana, jumping the state’s total to 56, health officials said Thursday. The statewide death toll remains at two.
Child Advocates celebrates ‘transformational’ $5M Lilly Endowment grant
Indiana’s largest organization that advocates for the interests of child victims of abuse has received the largest donation in its history — a $5 million grant from the Lilly Endowment. “They call it a transformational gift, and it certainly is for us,” Child Advocates CEO Cindy Booth said of the award.
Lilly wins another patent infringement case over cancer drug Alimta
Eli Lilly and Co. has won another patent-infringement lawsuit against a competitor who was preparing to launch an alternative form of the chemotherapy drug Alimta prior to its patent expiration in May 2022.
Indiana gets $8.4M from HHS to fight opioid epidemic
A federal agency has awarded Indiana $8.4 million to help fight the opioid epidemic by boosting access to substance abuse treatment and mental health services.